Gylden Pharma

Gylden Pharma

UK - Abingdon
Pharmaceutical
WebsiteLinkedInCareers Page

Focus: Vaccines using purely synthetic components to activate T-cells of the immune system

Gylden Pharma is a life sciences company focused on Vaccines using purely synthetic components to activate T-cells of the immune system.

Infectious DiseasesVaccines
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

PepGNP-ChikV
Chikungunya
Phase 1
Clinical Trials (1)
NCT07394426A Phase I Study of PepGNP-ChikV in Healthy Volunteers
Phase 1
LD vehicle-GNP
Dengue
Phase 1
Clinical Trials (1)
NCT04935801A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus
Phase 1
LD Vehicle-GNP
Coronavirus
Phase 1
Clinical Trials (1)
NCT05113862A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2
Phase 1
PepGNP-COVID19
Coronavirus
Phase 1/2
Clinical Trials (1)
NCT05633446Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 4 clinical trials